| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | 2.48e-06 | 1289 | 26 | 10 | GO:0005215 | |
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 4.89e-06 | 3 | 26 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 4.89e-06 | 3 | 26 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 8.60e-06 | 31 | 26 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.07e-05 | 1180 | 26 | 9 | GO:0022857 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.22e-05 | 459 | 26 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.23e-05 | 129 | 26 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.13e-05 | 151 | 26 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | channel activity | 4.72e-05 | 525 | 26 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.77e-05 | 526 | 26 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.10e-05 | 343 | 26 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.46e-04 | 18 | 26 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.94e-04 | 465 | 26 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.30e-04 | 749 | 26 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 4.48e-04 | 793 | 26 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 7.79e-04 | 140 | 26 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 8.40e-04 | 33 | 26 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | gated channel activity | 8.59e-04 | 334 | 26 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 8.91e-04 | 34 | 26 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.14e-03 | 627 | 26 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.47e-03 | 664 | 26 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.96e-03 | 193 | 26 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.08e-03 | 197 | 26 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 2.63e-03 | 758 | 26 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 2.67e-03 | 59 | 26 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 4.61e-03 | 78 | 26 | 2 | GO:0003725 | |
| GeneOntologyMolecularFunction | alcohol binding | 7.75e-03 | 102 | 26 | 2 | GO:0043178 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.49e-03 | 46 | 26 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | neuronal cell body | 3.28e-03 | 835 | 26 | 5 | GO:0043025 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 4.37e-03 | 1293 | 26 | 6 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 4.47e-03 | 1299 | 26 | 6 | GO:0098827 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 4.60e-03 | 1307 | 26 | 6 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 4.92e-03 | 1325 | 26 | 6 | GO:0012506 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 4.96e-03 | 1327 | 26 | 6 | GO:0042175 | |
| GeneOntologyCellularComponent | cell body | 5.18e-03 | 929 | 26 | 5 | GO:0044297 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.33e-03 | 88 | 26 | 2 | GO:0016529 | |
| Domain | SID1_TM_fam | 1.86e-06 | 2 | 26 | 2 | IPR025958 | |
| Domain | SID-1_RNA_chan | 1.86e-06 | 2 | 26 | 2 | PF13965 | |
| Domain | RIH_assoc | 2.79e-05 | 6 | 26 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.79e-05 | 6 | 26 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 2.79e-05 | 6 | 26 | 2 | PF01365 | |
| Domain | RIH_dom | 2.79e-05 | 6 | 26 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.79e-05 | 6 | 26 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.79e-05 | 6 | 26 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 2.79e-05 | 6 | 26 | 2 | PF08709 | |
| Domain | - | 2.79e-05 | 6 | 26 | 2 | 1.25.10.30 | |
| Domain | MIR | 8.33e-05 | 10 | 26 | 2 | PS50919 | |
| Domain | MIR | 8.33e-05 | 10 | 26 | 2 | PF02815 | |
| Domain | MIR | 8.33e-05 | 10 | 26 | 2 | SM00472 | |
| Domain | MIR_motif | 8.33e-05 | 10 | 26 | 2 | IPR016093 | |
| Domain | Ion_trans_dom | 5.20e-04 | 114 | 26 | 3 | IPR005821 | |
| Domain | Ion_trans | 5.20e-04 | 114 | 26 | 3 | PF00520 | |
| Domain | EF-hand_8 | 1.02e-03 | 34 | 26 | 2 | PF13833 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 2.04e-04 | 16 | 19 | 2 | M40060 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.90e-04 | 19 | 19 | 2 | M47760 | |
| Pubmed | TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. | 5.37e-07 | 2 | 26 | 2 | 16436382 | |
| Pubmed | A novel family of mammalian transmembrane proteins involved in cholesterol transport. | 5.37e-07 | 2 | 26 | 2 | 28785058 | |
| Pubmed | Common allosteric mechanisms between ryanodine and inositol-1,4,5-trisphosphate receptors. | 5.37e-07 | 2 | 26 | 2 | 21150295 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 26067272 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.07e-06 | 38 | 26 | 3 | 30786075 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 22100703 | ||
| Pubmed | TRPM7 activates m-calpain by stress-dependent stimulation of p38 MAPK and c-Jun N-terminal kinase. | 3.22e-06 | 4 | 26 | 2 | 20070945 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 23463619 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 8.05e-06 | 6 | 26 | 2 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 8.05e-06 | 6 | 26 | 2 | 16844763 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 11860456 | ||
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 20962236 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.50e-05 | 8 | 26 | 2 | 19033399 | |
| Pubmed | 1.87e-05 | 214 | 26 | 4 | 22199357 | ||
| Pubmed | 9.12e-05 | 19 | 26 | 2 | 19095219 | ||
| Pubmed | Genetic associations of brain structural networks in schizophrenia: a preliminary study. | 2.47e-04 | 31 | 26 | 2 | 20691427 | |
| Pubmed | 4.99e-04 | 44 | 26 | 2 | 20200978 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q13 | 6.95e-03 | 221 | 26 | 2 | chr3q13 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.57e-03 | 394 | 18 | 3 | 471 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.37e-02 | 181 | 18 | 2 | 694 | |
| Drug | strontium | 1.04e-06 | 68 | 26 | 4 | CID000104798 | |
| Drug | mag-fura-2 | 1.00e-05 | 37 | 26 | 3 | CID000123839 | |
| Drug | AC1Q7BER | 1.88e-05 | 6 | 26 | 2 | CID000005702 | |
| Drug | AC1L1DXE | 1.98e-05 | 299 | 26 | 5 | CID000002548 | |
| Drug | Br2BAPTA | 2.62e-05 | 7 | 26 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.62e-05 | 7 | 26 | 2 | CID009547999 | |
| Drug | NSC7524 | 5.15e-05 | 182 | 26 | 4 | CID000005657 | |
| Drug | Ferrichrome A | 5.61e-05 | 10 | 26 | 2 | CID006449886 | |
| Drug | R 478 | 6.85e-05 | 11 | 26 | 2 | CID000084223 | |
| Drug | 8-amino-cADPR | 6.85e-05 | 11 | 26 | 2 | CID003081323 | |
| Drug | LMWH | 8.34e-05 | 663 | 26 | 6 | CID000000772 | |
| Drug | Fura-2AM | 9.87e-05 | 79 | 26 | 3 | CID000105091 | |
| Drug | XeC compound | 1.18e-04 | 84 | 26 | 3 | CID000005701 | |
| Drug | Gvapspat amide | 1.30e-04 | 15 | 26 | 2 | CID000125015 | |
| Drug | borate | 1.87e-04 | 98 | 26 | 3 | CID000007628 | |
| Drug | nitrendipine | 1.87e-04 | 98 | 26 | 3 | CID000004507 | |
| Drug | indo-1 | 1.93e-04 | 99 | 26 | 3 | CID000105060 | |
| Drug | verapamil | 2.05e-04 | 490 | 26 | 5 | CID000002520 | |
| Drug | potassium hydroxide | 2.49e-04 | 108 | 26 | 3 | CID000014797 | |
| Drug | Phosphatidylinositol 4,5-Diphosphate | 2.60e-04 | 21 | 26 | 2 | ctd:D019269 | |
| Drug | AC1L1CR9 | 2.60e-04 | 21 | 26 | 2 | CID000002023 | |
| Drug | lamotrigine | 3.08e-04 | 116 | 26 | 3 | CID000003878 | |
| Drug | lithium chromate | 3.34e-04 | 296 | 26 | 4 | CID000026627 | |
| Drug | acetylleucyl-leucyl-norleucinal | 3.41e-04 | 24 | 26 | 2 | ctd:C063261 | |
| Drug | fluo-3 | 3.57e-04 | 122 | 26 | 3 | CID000104978 | |
| Drug | T0702 | 3.70e-04 | 25 | 26 | 2 | CID000005908 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 3.88e-04 | 308 | 26 | 4 | CID000001915 | |
| Drug | polyethylenimine | 4.11e-04 | 128 | 26 | 3 | CID000009033 | |
| Drug | glycidamide | 4.30e-04 | 130 | 26 | 3 | ctd:C071834 | |
| Drug | Zinc Oxide | 4.33e-04 | 317 | 26 | 4 | ctd:D015034 | |
| Drug | 5-deazariboflavin | 4.65e-04 | 28 | 26 | 2 | CID000159867 | |
| Drug | BAPTA | 4.70e-04 | 324 | 26 | 4 | CID000104751 | |
| Drug | pioglitazone | 4.81e-04 | 326 | 26 | 4 | CID000004829 | |
| Drug | lanthanum | 4.90e-04 | 136 | 26 | 3 | CID000023926 | |
| Drug | HEPES | 4.90e-04 | 136 | 26 | 3 | CID000023830 | |
| Drug | caged InsP3 | 5.00e-04 | 29 | 26 | 2 | CID000122248 | |
| Drug | AC1NUW3V | 5.00e-04 | 29 | 26 | 2 | CID005462126 | |
| Drug | carvacrol | 5.00e-04 | 29 | 26 | 2 | ctd:C073316 | |
| Drug | Dantrolene-13C3 | 5.91e-04 | 145 | 26 | 3 | CID000002951 | |
| Drug | nimodipine | 5.91e-04 | 145 | 26 | 3 | CID000004497 | |
| Drug | benzothiophene | 6.09e-04 | 32 | 26 | 2 | CID000007221 | |
| Drug | BAME | 6.09e-04 | 32 | 26 | 2 | CID000150869 | |
| Drug | AC1L1D9C | 6.21e-04 | 349 | 26 | 4 | CID000002250 | |
| Drug | macrocyclic inhibitor 4 | 6.48e-04 | 33 | 26 | 2 | CID016124959 | |
| Drug | CNS 1145 | 6.48e-04 | 33 | 26 | 2 | CID000190902 | |
| Drug | IHC-64 | 6.48e-04 | 33 | 26 | 2 | CID000162753 | |
| Drug | Soda | 6.88e-04 | 34 | 26 | 2 | CID000062596 | |
| Drug | PhTX-343 | 7.71e-04 | 36 | 26 | 2 | CID000159548 | |
| Drug | 4-chloro-m-cresol | 8.15e-04 | 37 | 26 | 2 | CID000001732 | |
| Drug | AC1L98DX | 8.60e-04 | 38 | 26 | 2 | CID000439957 | |
| Drug | valproate | 8.62e-04 | 381 | 26 | 4 | CID000003121 | |
| Drug | NAADP | 9.05e-04 | 39 | 26 | 2 | CID000123952 | |
| Drug | CID9959010 | 9.05e-04 | 39 | 26 | 2 | CID009959010 | |
| Drug | gabapentin | 9.21e-04 | 169 | 26 | 3 | CID000003446 | |
| Drug | diisopropylamine | 9.52e-04 | 40 | 26 | 2 | CID000007912 | |
| Drug | Dantrolene | 1.00e-03 | 41 | 26 | 2 | ctd:D003620 | |
| Drug | riluzole | 1.00e-03 | 174 | 26 | 3 | CID000005070 | |
| Drug | TMB-8 | 1.04e-03 | 176 | 26 | 3 | CID000005494 | |
| Drug | carbamazepine | 1.09e-03 | 179 | 26 | 3 | CID000002554 | |
| Drug | Pyoverdin | 1.10e-03 | 43 | 26 | 2 | CID005289234 | |
| Drug | LY341495 | 1.10e-03 | 43 | 26 | 2 | CID006324636 | |
| Disease | congestive heart failure (is_implicated_in) | 2.59e-04 | 27 | 26 | 2 | DOID:6000 (is_implicated_in) | |
| Disease | Alcoholic Intoxication | 3.64e-04 | 32 | 26 | 2 | C0001969 | |
| Disease | phosphatidylethanolamine measurement | 4.66e-04 | 173 | 26 | 3 | EFO_0010228 | |
| Disease | cholesteryl ester 18:3 measurement | 5.70e-04 | 40 | 26 | 2 | EFO_0010346 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 5.70e-04 | 40 | 26 | 2 | EFO_0004746 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 8.56e-04 | 49 | 26 | 2 | EFO_0006954, EFO_1001069 | |
| Disease | response to statin | 1.12e-03 | 56 | 26 | 2 | GO_0036273 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.69e-03 | 69 | 26 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | mean platelet volume | 1.76e-03 | 1020 | 26 | 5 | EFO_0004584 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AWVVFIAAFVKKLVY | 1076 | Q86UK0 | |
| ILDLVLYYNWKTVTV | 161 | P39086 | |
| LFYQKVIKYIWRIGT | 241 | Q15760 | |
| TWVEKYFDVYGKVVQ | 131 | O94923 | |
| WNYLYFIVLVRVKNK | 2566 | Q14573 | |
| KWYFIITIVIFVLQE | 371 | Q6UWP7 | |
| YEDGIYSVIQKKVTW | 1401 | O60449 | |
| YSVIQKKVTWYEALN | 1406 | O60449 | |
| VVTVFGVIIFKVYKW | 706 | Q9UN70 | |
| VLKAVDSYIWVQFLY | 141 | A4D1B5 | |
| WTVKYYELEEKIVSL | 4396 | P04114 | |
| QFLVTVVEKYKIYWV | 141 | Q6ZNA5 | |
| QLAKIKWVISVAFYV | 96 | O00258 | |
| EFYILWTKIQKYQKI | 596 | P17655 | |
| SIDVKYQIWKFGVIF | 4771 | P21817 | |
| LIWKNYKKYIIIAFI | 1816 | Q2WGJ9 | |
| VLRKKYQIYFWNIAT | 441 | Q8NBJ9 | |
| IQYNKVVKAQLWIYL | 146 | O14793 | |
| VLLVVGVSVIYVYWK | 381 | Q5TFQ8 | |
| FYVWKRVFQRYETVK | 356 | Q5BKT4 | |
| YYIIQIHFVKGVWEK | 11 | P40200 | |
| IVSKKYKIYFWNIIT | 436 | Q9NXL6 | |
| KIKYDWYQTESQVVI | 171 | Q9Y2Z0 | |
| KVYNYVKWIKNTIAA | 231 | P07477 | |
| LIFTVIYFSIWKGVK | 261 | P31645 | |
| EWIVIAYIFTYAIEK | 886 | Q96QT4 | |
| KFIIIFYVKEWSLLY | 571 | Q7Z402 |